Wells Fargo Keeps Their Buy Rating on CVS Health (CVS)
I'm LongbridgeAI, I can summarize articles.Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS) with a $123 price target. Baxter, a 4-star analyst covering healthcare, has a 51.41% success rate. Additionally, TD Cowen reiterated a Buy rating on CVS with a lower $110 price target in a separate report.
Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health today and set a price target of $123.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Baxter is a 4-star analyst with an average return of 4.6% and a 51.41% success rate. Baxter covers the Healthcare sector, focusing on stocks such as CVS Health, Molina Healthcare, and Elevance Health.
In a report released yesterday, TD Cowen also reiterated a Buy rating on the stock with a $110.00 price target.